Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe update changes the displayed ClinicalTrials.gov interface revision from v3.5.2 to v3.5.3, reflecting a site/version maintenance update rather than a study record change.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision v3.5.0 was added and the previous revision v3.4.3 was removed on the record history.SummaryDifference0.1%

- Check61 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check82 days agoChange DetectedNew history entries show the study status and recruitment status were updated to terminated and closed due to slow accrual (dates 2026-02-10 and 2026-02-12). The previous 'Completed' status was deleted (2026-02-11).SummaryDifference0.6%

- Check89 days agoChange DetectedNew history entries show the study as Completed, with updated Study Status and Recruitment Status, and introduce Contacts/Locations and Study Design sections, with Revision: v3.4.2 recorded on 2026-02-11. The older government funding notice and the prior Recruiting entry (2025-07-03, Revision: v3.4.1) were removed.SummaryDifference2%

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.